bpc-157 amino acids BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven BPC-157 vs. TB-500 | Peptides

B., Rasic Z., Sever M., Drmic D., et al

Bradnam LV, Frasca J, Kimberley TJ

availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial

4.2.2 NAM-competitive inhibitors NAM-competitive inhibitors are substances that can compete with the substrate NAM for the binding site in NNMT

Patients should also disclose all prescription medications, supplements, and allergies to help determine whether compounded peptide treatment is appropriate for their individual circumstances